Greyledge Technologies
Business Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10101 Ridgegate Pkwy Ste G01, Lone Tree,...Phone Number
(970) 236-8670Website
www.greyledgebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Greyledge Technologies
Greyledge Technologies is a clinical biotech company specializing in autologous cell therapeutics, particularly Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). They focus on refining and researching customized treatments for various medical applications, including orthopedics, dermatology, and cosmetic surgery. Their innovative approach emphasizes data analytics to enhance the quality and effectiveness of regenerative medicine. Greyledge partners with healthcare providers to offer advanced biologic treatments tailored to individual patient needs.Explore more
Greyledge Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Greyledge Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Greyledge Technologies launches new products
Funding: Get notified immidiatlly once Greyledge Technologies has new funding data
Greyledge Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Greyledge Technologies has recently received funding, and reach out quickly before it becomes old news!
Check out if Greyledge Technologies is spiking on competitors!
Earning: See what the market has to say on Greyledge Technologies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Greyledge Technologies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Greyledge Technologies
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Greyledge Technologies
Compare insights from companies similar to Greyledge Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Greyledge Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Greyledge Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Greyledge Technologies.
Greyledge Technologies Tech Stack
A closer look at the technologies used by Greyledge Technologies
See more technologies
Greyledge Technologies News & Media
James Johnston named to Greyledge Technologies Board of Directors
DENVER--(BUSINESS WIRE)---- $GLTI #biotech--James Johnston, an innovative executive with extensive financial and strategic experience with global organizations, has joined the board of directors of Greyledge Technologies, Inc. (“Greyledge” or “the Company”). He has served as Chief of Corporate Development for Greyledge since last fall. His extensive network of contacts, diverse strategic abilities and extensive experience in investment banking and private equity will continue to facilitate the cFormer Goldman Sachs VP Jim Johnston Joins Greyledge Technologies as Chief of Corporate Development
DENVER--(BUSINESS WIRE)---- $GLTI #biotech--Former VP of Goldman Sachs Jim Johnston is the newest member to join the board of Greyledge Technologies, Inc. (“Greyledge” or “the Company”). He has extensive experience in investment banking and early-stage private funding, which he will apply as Chief of Corporate Development. “It is an honor to welcome Mr. Johnston to the Greyledge Executive team,” says Dr. David Karli, Greyledge CEO and Founder. “His history of serial success and diverse experiencExperienced Executive and International Humanitarian Howard Ash Joins Greyledge Technologies as Member of the Board
DENVER--(BUSINESS WIRE)-- #David_Karli--Howard Ash joins Greyledge Technologies, Inc. (“Greyledge” or “the Company”) as a newly appointed member of the board. His vast network of contacts and profound strategic abilities, paired with extensive executive experience, are ideal qualifications to help him facilitate the cell therapeutics company’s expansion into new markets while maintaining its stringent quality standards. Founder and CEO, Dr. David Karli, expects Howard Ash’s involvement to furtheGreyledge Technologies Receives $2.5 Million Convertible Loan from Publicly-Traded Lender to Expand Cell Processing Facilities and Data Management Capability
DENVER--(BUSINESS WIRE)---- $FB #David_Karli--Greyledge Technologies Receives $2.5M Convertible Loan from Publicly-Traded Lender to Expand Cell Processing Facilities and Data Management Capability
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Greyledge Technologies
Sign Up For FreeTo access detailed company insights
Greyledge Technologies is a clinical biotech company specializing in autologous cell therapeutics, particularly Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). They focus on refining and researching customized treatments for various medical applications, including orthopedics, dermatology, and cosmetic surgery. Their innovative approa... Read More
